Armstrong Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.8K Hold
123
﹤0.01% 394
2026
Q1
$69.1K Hold
123
﹤0.01% 364
2025
Q4
$83.2K Buy
123
+70
+132% +$47.7K 0.01% 331
2025
Q3
$33.9K Buy
53
+19
+56% +$11.5K ﹤0.01% 470
2025
Q2
$18.2K Hold
34
﹤0.01% 555
2025
Q1
$14.1K Hold
34
﹤0.01% 573
2024
Q4
$14.1K Hold
34
﹤0.01% 573
2024
Q3
$17.2K Sell
34
-14
-29% -$6.8K ﹤0.01% 532
2024
Q2
$23.4K Buy
48
+14
+41% +$7.03K ﹤0.01% 473
2024
Q1
$18.9K Hold
34
﹤0.01% 490
2023
Q4
$18.9K Hold
34
﹤0.01% 490
2023
Q3
$14.9K Hold
34
﹤0.01% 542
2023
Q2
$17.1K Hold
34
﹤0.01% 514
2023
Q1
$17K Hold
34
﹤0.01% 500
2022
Q4
$13.9K Buy
+34
New +$13.2K ﹤0.01% 541

Other funds holding IDXX

Armstrong Advisory Group's IDXX Position: Q2 2026 in Review

Armstrong Advisory Group held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 123 shares worth $64.8K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

Armstrong Advisory Group first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $83.2K in Q4 2025. 235 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Armstrong Advisory Group held 123 shares of Idexx Laboratories worth $64.8K as of Q2 2026.
  • Armstrong Advisory Group left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #394 holding.
  • Armstrong Advisory Group first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Idexx Laboratories position peaked at $83.2K in Q4 2025.
  • 235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.